BridgeMD
New treatment option for Lymphoma
Official title Effects of Exercise Training in Survivors of Lymphoma
ClinicalTrials.gov ID: NCT06270667
What this study is testing
- What it's testing
- This study aims to compare the effects of aerobic exercise with or without addition of resistance exercise to usual care in individuals treated with anthracyclines for lymphomas and to compare exercise effects to age- and sex-matched individuals with no prior history of malignant diseases.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Lymphoma participants:
- Listed in relevant registers
- Confirmed lymphoma diagnosis (i.e., Hodgkin lymphoma and aggressive non-Hodgkin lymphoma)
- Completed treatment in the past two to five years without relapse or second cancer
- Previous anthracycline treatment with or without mediastinal radiation
You likely can't join if
- Lymphoma participants:
- Relapse since diagnosis
- A history, or current presence, of another diagnosis of invasive cancer of any kind Exclusion Criteria Lymphoma participants and non-cancer reference...
- Presence of any uncontrolled- or recent cardiovascular disease
- Has undergone heart surgery
- Uses a pacemaker
See the full eligibility criteria
- Lymphoma participants:
- Listed in relevant registers
- Confirmed lymphoma diagnosis (i.e., Hodgkin lymphoma and aggressive non-Hodgkin lymphoma)
- Completed treatment in the past two to five years without relapse or second cancer
- Previous anthracycline treatment with or without mediastinal radiation
- No severe cancer-related fatigue (per self-report) Lymphoma participants and non-cancer reference group:
- Currently not performing \>75 minutes/week of aerobic exercise
- Willing and able to adhere to all study procedures.
- Lymphoma participants:
- Relapse since diagnosis
- A history, or current presence, of another diagnosis of invasive cancer of any kind Exclusion Criteria Lymphoma participants and non-cancer reference group:
- Presence of any uncontrolled- or recent cardiovascular disease
- Has undergone heart surgery
- Uses a pacemaker
- Pregnancy
- Unable to read and understand Swedish (applicable for the Swedish site only)
- Unable to read and understand Norwegian (applicable for the Norwegian site)
- Any physical or mental health condition restricting adherence to study protocol
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
- Uppsala, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway; Uppsala, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.